Condition: Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) · Sponsor: Eli Lilly and Company
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The study will last about 18 months.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| AllerVie Clinical Research | Birmingham, Alabama, United States | Not Yet Recruiting |
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Medovation Research | Huntsville, Alabama, United States | Not Yet Recruiting |
| Novak Clinical Research - Tucson - North La Cholla Boulevard | Tucson, Arizona, United States | Not Yet Recruiting |
| Keck Medicine of USC | Arcadia, California, United States | Not Yet Recruiting |
| University of California, Irvine | Irvine, California, United States | Recruiting |
| ADCRC | La Mesa, California, United States | Not Yet Recruiting |
| Ark Clinical Research | Long Beach, California, United States | Not Yet Recruiting |
| DaVinci Research LLC | Roseville, California, United States | Recruiting |
| Breathe Clear Institute | Torrance, California, United States | Recruiting |
| Colorado ENT & Allergy | Colorado Springs, Colorado, United States | Recruiting |
| Bioresearch Partner-Kendale Lakes | Miami, Florida, United States | Not Yet Recruiting |
+ 190 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06338995